Evidence map›Paper›PMID 35425212›Full record

ArticleRSC advances2022

Effect of the enantiomeric structure of hydrophobic polymers on the encapsulation properties of a second near infrared (NIR-II) fluorescent dye for

Kotoe Ichihashi, Masakazu Umezawa, Yuichi Ueya, Kyohei Okubo, Eiji Takamoto, Takashi Matsuda, Masao Kamimura, Kohei Soga

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Kotoe IchihashiDepartment of Materials Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science 6-3-1 Niijuku Katsushika Tokyo 125-8585 Japan masa-ume@rs.tus.ac.jp mail@ksoga.com.
Masakazu UmezawaDepartment of Materials Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science 6-3-1 Niijuku Katsushika Tokyo 125-8585 Japan masa-ume@rs.tus.ac.jp mail@ksoga.com.ORCID https://orcid.org/0000-0002-3398-3993
Yuichi UeyaTsukuba Research Laboratories, JSR Corporation 25 Miyukigaoka Tsukuba Ibaraki 305-0841 Japan.
Kyohei OkuboDepartment of Materials Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science 6-3-1 Niijuku Katsushika Tokyo 125-8585 Japan masa-ume@rs.tus.ac.jp mail@ksoga.com.ORCID https://orcid.org/0000-0001-5744-3679
Eiji TakamotoTsukuba Research Laboratories, JSR Corporation 25 Miyukigaoka Tsukuba Ibaraki 305-0841 Japan.
Takashi MatsudaTsukuba Research Laboratories, JSR Corporation 25 Miyukigaoka Tsukuba Ibaraki 305-0841 Japan.
Masao KamimuraDepartment of Materials Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science 6-3-1 Niijuku Katsushika Tokyo 125-8585 Japan masa-ume@rs.tus.ac.jp mail@ksoga.com.ORCID https://orcid.org/0000-0001-8510-2935
Kohei SogaDepartment of Materials Science and Technology, Faculty of Advanced Engineering, Tokyo University of Science 6-3-1 Niijuku Katsushika Tokyo 125-8585 Japan masa-ume@rs.tus.ac.jp mail@ksoga.com.
Tokyo University of Science · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Over-thousand-nanometer (OTN) near-infrared (NIR) fluorophores are useful for biological deep imaging because of the reduced absorption and scattering of OTN-NIR light in biological tissues. IR-1061, an OTN-NIR fluorescent dye, has a hydrophobic and cationic backbone in its molecular structure, and a non-polar counter ion, BF

Identifiers

PMID35425212
PMCPMC8979197
OpenAlexW4206723215

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.